Focus on the latest trends and challenges in innovative drug development.

This session analyzes current hotspots and pain points in innovative drug R&D from multiple perspectives, including technology development, policy and regulations, and capital operations.

Guests will interact with on-site alumni to jointly discuss the development path of domestic innovative drugs.